The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer

Nutrition and Metabolism

Volumn 4, Issue , 2007, Pages

  Zhou, Weihua ^a   Mukherjee, Purna ^a   Kiebish, Michael A ^a   Markis, William T ^a   Mantis, John G ^a   Seyfried, Thomas N ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOCAL; NUTRACEUTICAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTOMA; BRAIN CANCER; CANCER GROWTH; CANCER SURVIVAL; CARBOHYDRATE DIET; COMPARATIVE STUDY; CONTROLLED STUDY; DIET THERAPY; ENERGY METABOLISM; EPILEPSY; GENE EXPRESSION; GLIOBLASTOMA; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; KETOGENIC DIET; LOW CALORY DIET; LOW FAT DIET; MICROVASCULATURE; MOUSE; NONHUMAN; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

MUS;

EID: 33847780073     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-4-5     Document Type: Article

References (80)

1. Brain tumors in the elderly: recent trends in a Minnesota cohort study. JK Lowry JJ Snyder PW Lowry, Arch Neurol 1998 55 922 928 10.1001/archneur.55.7. 922 9678309
2. No meeting of minds on childhood cancer. J Kaiser, Science 1999 286 1832 1834 10.1126/science.286.5446.1832 10610570
3. Population-based epidemiologic data on brain tumors in German children. P Kaatsch CH Rickert J Kuhl J Schuz J Michaelis, Cancer 2001 92 3155 3164 10.1002/1097-0142(20011215)92:12〈3155::AID-CNCR10158>3.0.CO;2-C 11753995
4. Trends in incidence of primary brain tumors in the United States, 1985-1994. PJ Jukich BJ McCarthy TS Surawicz S Freels FG Davis, Neuro-oncol 2001 3 141 151 10.1215/15228517-3-3-141 11465394
5. Targeting energy metabolism in brain cancer: review and hypothesis. TN Seyfried P Mukherjee, Nutr Metab (Lond) 2005 2 30 16242042 10.1186/1743-7075-2- 30
6. Malignant gliomas in 2005: where to GO from here? PG Fisher PA Buffler, Jama 2005 293 615 617 10.1001/jama.293.5.615 15687318
7. Profile of daily life in children with brain tumors: an assessment of health-related quality of life. SR Bhat TL Goodwin TM Burwinkle MF Lansdale GV Dahl SL Huhn IC Gibbs SS Donaldson RK Rosenblum JW Varni PG Fisher, J Clin Oncol 2005 23 5493 5500 10.1200/JCO.2005.10.190 16110009
8. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. TN Seyfried TM Sanderson MM El-Abbadi R McGowan P Mukherjee, Br J Cancer 2003 89 1375 1382 10.1038/sj.bjc.6601269 14520474
9. Anti-Angiogenic and Pro-Apoptotic Effects of Dietary Restriction in Experimental Brain Cancer: Role of Glucose and Ketone Bodies. TN Seyfried P Mukherjee, Integration/Interaction of Oncologic Growth New York: Kluwer Academic, Meadows GG, 2 2005 15 [Kaiser H (Series Editor): Cancer Growth and Progression]
10. Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. P Mukherjee LE Abate TN Seyfried, Clin Cancer Res 2004 10 5622 5629 10.1158/1078-0432.CCR-04-0308 15328205
11. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. P Mukherjee MM El-Abbadi JL Kasperzyk MK Ranes TN Seyfried, Br J Cancer 2002 86 1615 1621 10.1038/sj.bjc.6600298 12085212
12. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. AE Greene MT Todorova TN Seyfried, J Neurochem 2003 86 529 537 10.1046/j.1471-4159.2003.01862.x 12859666
13. Ketones: metabolism's ugly duckling. TB VanItallie TH Nufert, Nutr Rev 2003 61 327 341 10.1301/nr.2003.oct.327-341 14604265
14. Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. J Klepper S Diefenbach A Kohlschutter T Voit, Prostaglandins Leukot Essent Fatty Acids 2004 70 321 327 10.1016/j.plefa.2003.07.004 14769490
15. Ketonic diet in the management of pyruvate dehydrogenase deficiency. RE Falk SD Cederbaum JP Blass GE Gibson RA Kark RE Carrel, Pediatrics 1976 58 713 721 824610
16. A zebrafish model for pyruvate dehydrogenase deficiency: rescue of neurological dysfunction and embryonic lethality using a ketogenic diet. MR Taylor JB Hurley HA Van Epps SE Brockerhoff, Proc Natl Acad Sci USA 2004 101 4584 4589 15070761 10.1073/pnas.0307074101
17. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. RL Veech, Prostaglandins Leukot Essent Fatty Acids 2004 70 309 319 10.1016/j.plefa.2003.09.007 14769489
18. Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. JG Mantis NA Centeno MT Todorova R McGowan TN Seyfried, Nutr Metab (Lond) 2004 1 11 15507133 10.1186/1743-7075-1-11
19. Role of acetoacetyl-CoA synthetase in acetoacetate utilization by tumor cells. MJ Tisdale, Cancer Biochem Biophys 1984 7 101 107 6147189
20. Cerebral ketone body metabolism. AA Morris, J Inherit Metab Dis 2005 28 109 121 10.1007/s10545-005-5518-0 15877199
21. Growth-inhibitory effects of the ketone body, monoacetoacetin, on human gastric cancer cells with succinyl-CoA: 3-oxoacid CoA-transferase (SCOT) deficiency. M Sawai M Yashiro Y Nishiguchi M Ohira K Hirakawa, Anticancer Res 2004 24 2213 2217 15330163
22. Ketone bodies, potential therapeutic uses. RL Veech B Chance Y Kashiwaya HA Lardy GF Cahill Jr, IUBMB Life 2001 51 241 247 11569918
23. Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer. AP John, Med Hypotheses 2001 57 429 431 10.1054/mehy.2001.1335 11601863
24. On the origin of cancer cells. O Warburg, Science 1956 123 309 314 10.1126/science.123.3191.309 13298683
25. Metabolic patterns in malignant gliomas. J Meixensberger B Herting W Roggendorf H Reichmann, J Neurooncol 1995 24 153 161 10.1007/BF01078485 7562002
26. Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. S Oudard E Boitier L Miccoli S Rousset B Dutrillaux MF Poupon, Anticancer Res 1997 17 1903 1911 9216643
27. Relationship between blood flow, glucose metabolism, protein synthesis, glucose and ATP content in experimentally-induced glioma (RG1 2.2) of rat brain. G Mies W Paschen G Ebhardt KA Hossmann, J Neurooncol 1990 9 17 28 10.1007/BF00167064 2213113
28. Metabolic Control of Brain Cancer: Role of Glucose and Ketone Bodies. TN Seyfried P Mukherjee E Adams T Mulroony LE Abate, Proc Amer Assoc Cancer Res 2005 46 1147
29. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. LC Nebeling F Miraldi SB Shurin E Lerner, J Am Coll Nutr 1995 14 202 208 7790697
30. Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans. LB Mahoney CA Denny TN Seyfried, Lipids Health Dis 2006 5 13 16709251 10.1186/1476-511X-5-13
31. JM Freeman JB Freeman MT Kelly, The Ketogenic Diet: A Treatment for Epilepsy New York: Demos third 2000
32. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. HC Kang E Chung da DW Kim HD Kim, Epilepsia 2004 45 1116 1123 10.1111/j.0013-9580.2004.10004.x 15329077
33. The ketogenic diet: an effective medical therapy with side effects. JW Wheless, J Child Neurol 2001 16 633 635 11575600
34. JM Freeman EH Kossoff JB Freeman MT Kelly, The Ketogenic Diet: A Treatment for Children and Others with Epilepsy New York: Demos Fourth 2007
35. KetoCal®, a novel ketogenic diet therapy for brain cancer. W Zhou P Mukherjee KA Kiebish JG Mantis KN Gorham TJ Mulrooney WT Markis TN Seyfried, Proc Amer Assoc Cancer Res 2006 47 3887
36. Enhanced aspartate release from hippocampal slices of epileptic (El) mice. HJ Flavin A Wieraszko TN Seyfried, J Neurochem 1991 56 1007 1011 10.1111/j.1471-4159.1991.tb02021.x 1671582
37. Ganglioside distribution in murine neural tumors. TN Seyfried M El-Abbadi ML Roy, Mol Chem Neuropathol 1992 17 147 167 1418222
38. Experimental brain tumors: I. tumors produced with methylcholanthrene. HM Zimmerman H Arnold, Cancer Res 1941 1 919 938
39. Influence of ganglioside GM3 and high density lipoprotein (HDL) on the cohesion of mouse brain tumor cells. H Bai TN Seyfried, J Lipid Res 1997 38 160 172 9034210
40. Tumor-infiltrating macrophages contribute to the glycosphinglipid composition of brain tumors. JA Ecsedy HC Yohe AJ Bergeron TN Seyfried, J Lipid Res 1998 39 2218 2227 9799808
41. N-butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. MK Ranes M El-Abbadi MG Manfredi P Mukherjee FM Platt TN Seyfried, Br J Cancer 2001 84 1107 1114 10.1054/bjoc.2000.1713 11308262
42. The influence of ImuVert, a biological response modifier, on the growth and ganglioside composition of murine neural tumors. M Cotterchio TN Seyfried, Mol Chem Neuropathol 1993 20 163 172 8297420
43. Long term culture of normal and neoplastic human glia. J Ponten EH Macintyre, Acta Pathol Microbiol Scand 1968 74 465 486 4313504
44. Expression of mouse sialic acid on gangliosides of a human glioma grown as a xenograft in SCID mice. JA Ecsedy KA Holthaus HC Yohe TN Seyfried, J Neurochem 1999 73 254 259 10.1046/j.1471-4159.1999.0730254.x 10386978
45. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. A Malik F Afaq S Sarfaraz VM Adhami DN Syed H Mukhtar, Proc Natl Acad Sci USA 2005 102 14813 14818 16192356 10.1073/pnas.0505870102
46. Determination of subcutaneous tumor size in athymic (nude) mice. MM Tomayko CP Reynolds, Cancer Chemother Pharmacol 1989 24 148 154 10.1007/BF00300234 2544306
47. Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood. DH Williamson J Mellanby HA Krebs, Biochem J 1962 82 90 96 14007241
48. The role of ketone bodies in caloric homeostasis. HA Krebs DH Williamson MW Bates MA Page RA Hawkins, Adv Enzyme Reg 1971 9 387 409 10.1016/S0065- 2571(71)80055-9
49. NV Bhagavan, Medical Biochemistry New York: Harcourt Fourth 2002
50. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Weidner JP Semple WR Welch J Folkman, N Engl J Med 1991 324 1 8 1701519
51. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. P Mukherjee AV Sotnikov HJ Mangian JR Zhou WJ Visek SK Clinton, J Natl Cancer Inst 1999 91 512 523 10.1093/jnci/91.6.512 10088621
52. Gene-linked shift in ganglioside distribution influences growth and vascularity in a mouse astrocytoma. LE Abate P Mukherjee TN Seyfried, J Neurochem 2006 98 1973 1984 10.1111/j.1471-4159.2006.04097.x 16911584
53. TA Lang M Secic, How to Report Statistics in Medicine Philadelphia: Amer. College Physicians 1997
54. Nutrition. WG Hoag MM Dickie, Biology of the Laboratory Mouse New York: Dover, Green EL, second 1968
55. The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. MT Todorova P Tandon RA Madore CE Stafstrom TN Seyfried, Epilepsia 2000 41 933 940 10.1111/j.1528-1157.2000.tb00275.x 10961617
56. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. AE Greene MT Todorova R McGowan TN Seyfried, Epilepsia 2001 42 1371 1378 10.1046/j.1528-1157.2001.17601.x 11879337
57. Anti-inflammatory mechanisms of dietary restriction in slowing aging processes. TE Morgan AM Wong CE Finch, Interdiscip Top Gerontol 2007 35 83 97 17063034
58. The influence of diet on transplanted and spontaneous mouse tumors. P Rous, J Exp Med 1914 20 433 451 10.1084/jem.20.5.433
59. Ketogenic diet reduces hypoglycemia-induced neuronal death in young rats. KA Yamada N Rensing LL Thio, Neurosci Lett 2005 385 210 214 10.1016/j.neulet.2005.05.038 15975714
60. D-beta-hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures. R Masuda JW Monahan Y Kashiwaya, J Neurosci Res 2005 80 501 509 10.1002/jnr.20464 15825191
61. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease. K Imamura T Takeshima Y Kashiwaya K Nakaso K Nakashima, J Neurosci Res 2006 84 1376 1384 10.1002/jnr.21021 16917840
62. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Y Kashiwaya T Takeshima N Mori K Nakashima K Clarke RL Veech, Proc Natl Acad Sci USA 2000 97 5440 5444 10805800 10.1073/pnas.97.10.5440
63. Ketoacids? Good medicine? GF Cahill Jr RL Veech, Trans Am Clin Climatol Assoc 2003 114 149 161 discussion 162-143 12813917
64. Ketone body synthesis in the brain: possible neuroprotective effects. M Guzman C Blazquez, Prostaglandins Leukot Essent Fatty Acids 2004 70 287 292 10.1016/j.plefa.2003.05.001 14769487
65. The inhibition of malignant cell growth by ketone bodies. BA Magee N Potezny AM Rofe RA Conyers, Aust J Exp Biol Med Sci 1979 57 529 539 548019
66. Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues. MJ Tisdale RA Brennan, Br J Cancer 1983 47 293 297 6130780
67. 3-Oxo acid coenzyme A transferase activity in brain and tumors of the nervous system. M Fredericks RB Ramsey, J Neurochem 1978 31 1529 1531 10.1111/j.1471-4159.1978.tb06581.x 298319
68. Ketone-body metabolism in tumour-bearing rats. AM Rofe R Bais RA Conyers, Biochem J 1986 233 485 491 3954747
69. O Warburg, The Metabolism of Tumours New York: Richard R. Smith 1931
70. Late-Occurring Stroke Among Long-Term Survivors of Childhood Leukemia and Brain Tumors: A Report From the Childhood Cancer Survivor Study. DC Bowers Y Liu W Leisenring E McNeil M Stovall JG Gurney LL Robison RJ Packer KC Oeffinger, J Clin Oncol 2006 17088567
71. Growth failure after treatment of pediatric brain tumors. CL Clarson RF Del Maestro, Pediatrics 1999 103 E37 10.1542/peds.103.3.e37 10049993
72. [Influence of surgery and radiotherapy on growth and pubertal development in children treated for brain tumour]. D Birkholz M Korpal-Szczyrska H Kaminska E Bien K Polczynska T Stachowicz-Stencel A Szolkiewicz, Med Wieku Rozwoj 2005 9 463 469 16719158
73. Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. LC Nebeling E Lerner, J Am Diet Assoc 1995 95 693 697 10.1016/S0002-8223(95)00189-1 7759747
74. Prevention of mouse skin tumor promotion by dietary energy restriction requires an intact adrenal gland and glucocorticoid supplementation restores inhibition. JW Stewart K Koehler W Jackson J Hawley W Wang A Au R Myers DF Birt, Carcinogenesis 2005 26 1077 1084 10.1093/carcin/bgi051 15746164
75. Mechanisms by which energy restriction inhibits rat mammary carcinogenesis: in vivo effects of corticosterone on cell cycle machinery in mammary carcinomas. Z Zhu W Jiang HJ Thompson, Carcinogenesis 2003 24 1225 1231 10.1093/carcin/bgg077 12807724
76. The glucocorticoid paradox of caloric restriction in slowing brain aging. NV Patel CE Finch, Neurobiol Aging 2002 23 707 717 10.1016/S0197-4580(02)00017- 9 12392776
77. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. MJ Tisdale RA Brennan KC Fearon, Br J Cancer 1987 56 39 43 3620317
78. Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer? JC Mavropoulos WB Isaacs SV Pizzo SJ Freedland, Urology 2006 68 15 18 10.1016/j.urology.2006.03.073 16844447
79. Diet therapy in refractory pediatric epilepsy: increased efficacy and tolerability. HC Kang HD Kim, Epileptic Disord 2006 8 309 316 17150447
80. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. HH Pfeifer EA Thiele, Neurology 2005 65 1810 1812 10.1212/01.wnl.0000187071.24292.9e 16344529